ESR1 and breast carcinoma: Although previous studies showed that patients with AR+ breast tumors showed prolonged survival and better response to hormone treatments, as androgens levels are positively associated with breast cancer risk in post-menopausal women, suggesting that It may be the AR expression that correlates with ER expression, but more studies are needed to prove this.